|1.50||+0.1101||+7.92%||Vol 753.64K||1Y Perf 17.92%|
|Apr 13th, 2021 15:49 DELAYED|
|- -%||- -|
|Target Price||2.00||Analyst Rating||Strong Buy 1.50|
|Potential %||34.68||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-100/20/56||Value Ranking||— -|
|Insiders Value % 3/6/12 mo.||-100/-98/-97||Growth Ranking||— -|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-96/-94||Income Ranking||— -|
|Market Cap||29.77M||Earnings Rating||Neutral|
|Price Range Ratio 52W %||13.44||Earnings Date||25th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||25th May 2021|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||751.41K|
|Avg. Monthly Volume||2.69M|
|Avg. Quarterly Volume||2.35M|
BioHiTech Global Inc. (NASDAQ: BHTG) stock closed at 1.39 per share at the end of the most recent trading day (a -12.58% change compared to the prior day closing price) with a volume of 881.14K shares and market capitalization of 29.77M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Industrial Products industry, Industrials sector and employs 39 people. BioHiTech Global Inc. CEO is Anthony Fuller.
The one-year performance of BioHiTech Global Inc. stock is 17.92%, while year-to-date (YTD) performance is 24.11%. BHTG stock has a five-year performance of -65.68%. Its 52-week range is between 1.0498 and 4.4, which gives BHTG stock a 52-week price range ratio of 13.44%
BioHiTech Global Inc. currently has a PE ratio of -2.60, a price-to-book (PB) ratio of 35.36, a price-to-sale (PS) ratio of 13.68, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -19.13%, a ROC of -% and a ROE of 739.16%. The company’s profit margin is -%, its EBITDA margin is -193.00%, and its revenue ttm is $2.02 Million , which makes it $0.10 revenue per share.
Of the last four earnings reports from BioHiTech Global Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. BioHiTech Global Inc.’s next earnings report date is 25th May 2021.
The consensus rating of Wall Street analysts for BioHiTech Global Inc. is Strong Buy (1.5), with a target price of $2, which is +34.68% compared to the current price. The earnings rating for BioHiTech Global Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
BioHiTech Global Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
BioHiTech Global Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 24.78, ATR14 : 0.27, CCI20 : -114.66, Chaikin Money Flow : -0.44, MACD : -0.09, Money Flow Index : 49.58, ROC : -12.03, RSI : 41.75, STOCH (14,3) : 4.35, STOCH RSI : 0.38, UO : 45.52, Williams %R : -95.65), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of BioHiTech Global Inc. in the last 12-months were: Anthony Fuller (Buy at a value of $12 910), Frank E. Celli (Buy at a value of $2 846), Frank E. Celli (Sold 359 774 shares of value $1 091 587 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.